Minneapolis, MN, United States of America

Leo T Furcht

This inventor holds 38 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Multipotent Stem Cells. Top assignees: Regents of the University of Minnesota, Abt Holding Company, Healios K.k.. Active years: 1989-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leo T Furcht. Retrieved from https://idiyas.com/inventor/leo-t-furcht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 2)

% Patents Active = 89.5

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.6

ph-index = 14

Forward Citations = 912(Granted Patents)

Location History:

Golden Valley, BE (2017)
Golden Valley, MN (US) (2011 - 2018)
Minneapolis, MN (US) (1989 - 2020)

Company Filing History:

33 out of 2,372

Regents of the University of Minnesota

The United States of America as Represented by the Department of Health

patents

6. 1 out of 28

The United States of America as Represented by the Secretary of Health

patents

7. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2024

Loading Chart...

Areas of Expertise:

Multipotent Stem Cells

Bone Marrow

Isolation Methods

Myocardial Infarction

Congestive Heart Failure

Polypeptides

Biocompatible Materials

Genetic Testing

Cell Adhesion

Synthetic Fibronectin

Inhibitors

Monoclonal Antibodies

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171785 - Pluripotent cells derived from bone marrow and methods for isolation (2024-12-24),

2. 10638734 - Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof (2020-05-05),

3. 10226485 - Multipotent adult stem cells and methods for isolation (2019-03-12),

4. 10006004 - Multipotent adult stem cells and methods for isolation (2018-06-26),

5. 9974811 - Multipotent adult stem cells and methods for isolation (2018-05-22),

6. 9974810 - Multipotent adult stem cells and methods for isolation (2018-05-22),

7. 9974809 - Multipotent adult stem cells and methods for isolation (2018-05-22),

8. 9789136 - Multipotent adult stem cells and methods for isolation (2017-10-17),

9. 9526747 - Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure (2016-12-27),

10. 8075881 - Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure (2011-12-13),

11. 7838289 - Assay utilizing multipotent adult stem cells (2010-11-23),

12. 7659118 - Multipotent adult stem cells (2010-02-09),

13. 7015037 - Multiponent adult stem cells and methods for isolation (2006-03-21),

14. 6849712 - Peptides with β1 integrin subunit dependent cell adhesion modulating activity (2005-02-01),

15. 6303288 - Integrated microchip genetic testing system (2001-10-16),

Title: Innovator Spotlight: Leo T Furcht - Pioneering Adult Stem Cell Research

Introduction:

Leo T Furcht, a prolific inventor hailing from Minneapolis, MN, has left an indelible mark on the field of adult stem cell research. With an impressive portfolio of 37 patents to his name and groundbreaking innovations in the realm of multipotent adult stem cells (MASC), Furcht's contributions have significantly advanced regenerative medicine and therapeutic treatment possibilities.

Latest Patents:

Among his latest patents, Furcht focuses on multipotent adult stem cells, their sources, methods of obtaining and maintaining them, differentiation processes, and therapeutic applications. The inventions delve into the isolation and cultivation of non-embryonic stem cells capable of differentiating into various tissue types, offering promising avenues for disease treatment and tissue regeneration.

Career Highlights:

Leo T Furcht has been instrumental in the world of academia and industry, having made significant strides in research and development. Some of the notable companies he has been associated with include the University of Minnesota and Abt Holding Company, where his expertise has been leveraged to push the boundaries of stem cell science and biotechnology.

Collaborations:

Throughout his illustrious career, Furcht has collaborated with esteemed professionals in the field, including the likes of Catherine M Verfaillie and Morayma Reyes. Together, they have contributed to pioneering research endeavors, further solidifying Furcht's reputation as a leading figure in the realm of adult stem cell innovations.

Conclusion:

Leo T Furcht's groundbreaking work in the realm of multipotent adult stem cells underscores his unwavering commitment to pushing the boundaries of scientific discovery and medical advancements. His patents and collaborative efforts continue to pave the way for novel therapeutic interventions and regenerative treatments, shaping the landscape of modern biotechnology and healthcare.

Profile summary based on public USPTO records.